1. Introduction {#sec1}
===============

The NAGNAG alternative splicing mechanism is a process which facilitates alternative protein expression from a single gene. Analysis of deep RNA-sequencing data by Bradley et al. (2012) confirmed that NAGNAG is highly regulated \[[@B1]\]. NAGNAG alternative splicing specifically targets inclusion or exclusion of three nucleotides at 3′ splice sites ([Figure 1](#fig1){ref-type="fig"}), thus effecting a change in one or two amino acids encoded in the final protein \[[@B2]--[@B9]\]. Such amino acid substitutions have been shown to affect protein function and interfere with signaling \[[@B10]\], affect cellular localization \[[@B11]\], and impact on DNA and protein binding \[[@B12]--[@B14]\] in both plants and mammals. A role for NAGNAG alternative splicing was shown in human Stargardt disease \[[@B15]\] and has been implicated in other disease processes including cancer \[[@B16]\].

Large intergenic noncoding RNAs (lincRNAs) have traditionally been defined as long noncoding transcripts greater than 200 nucleotides in length. Overlapping isoforms of lincRNA have been reported previously and may include protein-coding genes \[[@B17]\]. Recently, while exploring the dynamic profiles of NAGNAG acceptors in Arabidopsis, we identified two isoforms originating from the same NAGNAG acceptors but located in noncoding RNA \[[@B18]\]. To date, previous studies have assumed NAGNAG acceptors function through the classical mRNA paradigm based on observation of altered coding for one or two amino acids in the protein-coding gene. Based on this observation of NAGNAG acceptors in Arabidopsis, we proposed an expanded paradigm and hypothesized that NAGNAG alternative splicing mechanism also exists in lincRNA.

Bioinformatics has become a powerful tool for the study of alternative splicing and its functional consequence. To date, bioinformatic analyses have produced evidence of alternative splicing in approximately 80% of human genes \[[@B19]\]. Bioinformatic approaches have been invaluable for exploring comparative genomics across species and such studies have produced important insights into regulatory mechanisms governing splicing and its role in evolution and adaptation. Single base-pair resolution offered by deep RNA sequencing motivated us to find further direct evidence of NAGNAG alternative splicing in lincRNA. To accomplish this goal we applied computational approaches to two public datasets of deeply-sequenced human tissue genomic data whose content included previously annotated lincRNA. By aligning the two RNA-seq data sets and systematically screening, identifying, and quantifying the NAGNAG alternative splicing of lincRNA, 31 NAGNAG alternative splicing events in lincRNA were defined. Importantly, tissue-specific patterns of expression for NAGNAG isoforms in lincRNA were observed.

2. Methods {#sec2}
==========

2.1. Data {#sec2.1}
---------

RNA-seq data sets were downloaded from NCBI SRA (accession number for data sets 1 and 2: E-MTAB-513 and GSE30554). These RNA-seq data were generated by sequencing 8 individual human tissues and mixture of 16 tissues (Illumina Body Map) using the Illumina HiSeq 2000 (Illumina, Inc.) platform. Each sample was deeply sequenced with more than 200 million reads and annotated for lincRNA. We only kept the high-quality reads using FastX quality filter with the following criteria: minimum of 20 Phred score over at least 80% of the sequence read.

2.2. Alignment, Screening, and Quantification {#sec2.2}
---------------------------------------------

Annotations of human lincRNA were obtained from Human lincRNA Catalog hosted at Broad Institute \[[@B20]\]. All RNA-seq datasets were aligned to lincRNA with tophat \[[@B21]\] using the "-max-multihits 1", which only permits unique mapping. The anchor length of the software was set at 8 nt and the mismatch number in these regions at 0 nt to avoid alignment bias. After the data were aligned, sequence postprocessing tool (SAMtools) was used to store, sort, and index the binary SAM data (bam files) with respect to sequence alignment (<http://samtools.sourceforge.net>) \[[@B22]\].

To identify lincRNA containing NAGNAG alternative splicing sites, we screened the lincRNA sequences using the classical expression of the "NAGNAG" motif. Alignment of RNA-seq reads to the NAGNAG splicing junctions was used to confirm and validate the existence of the splice sites. We required at least four junction reads with the same 5′ splice sites, stipulating that two needed to match the first NAGNAG splice site (site 1) while the other two were required to match the second NAGNAG splice site (site 2) \[[@B23], [@B24]\].

The sequences for splice sites and the 30 bp exonic and intronic flanking sequences were extracted based on hg19 genome sequence with Bioconductor package Biostrings (R package version 2.22.0). Sequence logos were drawn by WebLogo with default parameters as described previously \[[@B25]\]. Two flanking sequences of the NAGNAG acceptors, including 30 bp from intron and 30 bp from exon, were extracted and screened for the potential patterns. The ratio of isoform expression at two alternative splice sites (site 1 and site 2) was calculated as log(read counts at side 1*⁄*read counts at side 2). NAGNAG acceptors were grouped into four categories based on this ratio and the strand information. If the expression of isoform 1 was more than that of isoform 2, ratio \> 0; otherwise, ratio \< 0.

To quantify RNA expression levels, all RNA-seq counts were normalized using reads per million (RPM). The expression level of NAGNAG isoforms in lincRNA was calculated by read counts through Bioconductor package Rsamtools (R package version 1.6.3) and IRanges (R package version 1.12.6). Duplicate reads were kept for quantification purpose. NAGNAG motifs were only designated as NAGNAG acceptors if two splice sites exhibited more than 2 reads in at least two samples. To avoid ambiguity, we discarded those NAGNAG acceptors located in the overlapping area between lincRNAs and annotated genes.

2.3. Quantification of Tissue-Specific NAGNAG Acceptors {#sec2.3}
-------------------------------------------------------

To analyze the relationship between the ratio of two NAGNAG splice sites and the tissues, we used Bioconductor package limma through the linear model: $$\begin{matrix}
{Y_{ijk} = \alpha_{i} + \beta_{j} + \varepsilon_{ijk},} \\
\end{matrix}$$ where *Y* represents the log ratio of two NAGNAG splice sites from the same NAGNAG acceptor, with NAGNAG acceptor *i*, tissue *j*, and sample *k*; *α* represents the main effect of *i*th NAGNAG acceptor; *β* represents the main effect of *j*th tissue; *ε* represents the measurement error. The NAGNAG acceptors were selected using false discovery rate (FDR)-adjusted *P* values \< 0.05.

3. Results {#sec3}
==========

Two novel observations were documented. First, mapping of unique reads to the potential NAGNAG alternative splicing sites in human lincRNA demonstrated existence of NAGNAG alternative splicing in lincRNA ([Table 1](#tab1){ref-type="table"}). Of the 1320 lincRNAs containing the NAGNAG motif, presence of NAGNAG acceptors was confirmed with RNA-seq data in 30 lincRNAs. These 31 NAGNAG acceptors originate from 30 transcripts. Interestingly, linc-POLR3G-10 exhibited two NAGNAG acceptors located in two distinct transcripts: TCONS_00010012 and TCONS_00010010. Presence of two NAGNAG acceptors was identified in the upstream region of the fourth and fifth exons of this 5-exon gene. In addition, 8 NAGNAG acceptors were identified within the overlapping regions between lincRNA and protein-coding RNA but were not further considered in this study (see Supplementary Data 1 in Supplementary Material available online at <http://dx.doi.org/10.1155/2014/736798>).

Most exons in lincRNA containing NAGNAG acceptors exceeded protein-coding genes in length (Wilcoxon rank sum test, *P* value \< 2.2*e* − 16). The average exon length of protein-coding genes ranged between 306 ± 702 bp and the average neighbouring intron length ranged between 6092 ± 19983 bp (Supplementary Figure S1), compared to the average exon and intron length of lincRNA which ranged between 349 ± 630 bp and 8476 ± 19751 bp, respectively. Most tandem acceptors of lincRNA occurred at the furthest exon, that is, second exon occurring in the lincRNA (mean: 2.52; sd: 0.71) whereas those found in protein-coding genes were found centrally located among all of the exons occurring in the gene (mean: 10.7; sd: 8.8). The most prevalent triplet found among the lincRNA sequences was CAG for both splice sites, with GAG present at lowest frequency (Supplementary Table S1). CAGCAG and CAGAAG combinations occurred at highest frequency. Positive correlation with the expression level was found when CAG was encoded relative to splice site selection. Specifically, a predilection for the first splice site was noted when CAG was encoded at the first NAG site (ratio \> 0, [Figure 2](#fig2){ref-type="fig"}). Alternatively, when CAG was located at the second NAG position or was absent from the splice site altogether, the second NAG was favoured for splicing (ratio \< 0, [Figure 2](#fig2){ref-type="fig"}).

The second novel observation was demonstration of tissue-specific properties by 6 NAGNAG acceptors in lincRNA (FDR adjusted *P* value \< 0.05). [Figure 3](#fig3){ref-type="fig"} shows that 6 of 31 NAGNAG acceptors exhibited statistically significant differences in expression levels across diverse tissues. Specifically, as seen in [Figure 3](#fig3){ref-type="fig"}, the first NAG splice site is specifically targeted by the NAGNAG acceptor: chr5:87583253-87583256\_+ from TCONS_00010012. Presence of these splice sites was associated with a clear expression pattern in several tissues including lymph node, lung, and kidney, and this signature was remarkably consistent. Moreover, a similar pattern for the alternative splice sites was noted and the second NAG splice site was specifically targeted by NAGNAG acceptors: chr15:95753867-95753870\_-. This distinctive expression pattern was clearly evident in ovary. Twenty-five of NAGNAG acceptors were notably absent or exhibited no difference in expression pattern across most tissues.

4. Discussion {#sec4}
=============

Splice sites are pivotal factors in the splicing process \[[@B26]\]. NAGNAG alternative splicing was identified in the past decade and is characterized by inclusion or exclusion of three nucleotides at 3′ splice sites, resulting in substitutions in one or two amino acids in the protein products. Previous studies have shown that this type of alternative splicing is highly regulated and related to proteome evolution \[[@B1]\]. Functionally, NAGNAG alternative splicing in mRNA results in various isoforms which generate alternative proteins following translation.

To the best of our knowledge, the present study provides the first evidence that NAGNAG alternative splicing can be observed not only in mRNA but also in lincRNA. Although alternative splicing of lincRNA was reported previously \[[@B20]\], the report of NAGNAG alternative splicing is novel. Following analysis of two RNA-seq data sets including annotations for lincRNA, we identified 31 NAGNAG acceptors in lincRNA. These 31 NAGNAG acceptors originated from 30 transcripts. Interestingly, a role for "CAG" sequence was suggested in splice site selection with CAG being the most prevalent triplet found among the lincRNA sequences for both splice sites. GAG was present at lowest frequency and CAGCAG and CAGAAG combinations occurred at highest frequency. A predilection for the first splice site was noted when CAG was encoded at the first NAG site. The second NAG was favoured for splicing when CAG was located at the second NAG position or was absent altogether. This finding is consistent with the previous reports about mRNA \[[@B27]\].

Traditionally, lincRNA has been defined as stretches of DNA transcripts exceeding 200 base pairs in length which do not encode putative functional protein products \[[@B28]\]. lincRNA has been posited to play a role in splicing processes \[[@B29]\] and has been reported to contain predominately two exons \[[@B30]\]. In the current study, most exons from lincRNA containing NAGNAG acceptors exceeded protein-coding genes in length. Most tandem acceptors of lincRNA identified in the present study occurred at the furthest exon, that is, the second exon occurring in the lincRNA. By contrast those found in protein-coding genes have generally been found centrally located among all of the exons occurring in the gene.

The mechanism of this NAGNAG alternative splicing is not completely understood. Hiller and colleagues \[[@B3]\] suggested that these NAGNAG acceptors are not random noise because some fraction of NAGNAG acceptors is tissue-specific, although this theory was not universally shared by others \[[@B6], [@B8]\]. However, Bradley et al. provided solid evidence in support of tissue specificity based on RNA-seq analysis of 16 human and 8 mouse tissues wherein they demonstrated that at least 25% of NAGNAG acceptors in mRNA were regulated in a tissue-specific manner \[[@B1]\]. This percentage exceeded earlier estimates for tissue specificity \[[@B27]\]. Analysis of our selected datasets revealed low levels of consistent tissue-specific patterns relative to NAGNAG acceptors in lincRNA. Among 19% of NAGNAG acceptors that exhibited distinct differences in expression levels of certain tissues, targeting of specific splicing pattern among two NAGNAG acceptors was noted.

There are some limitations of this computational study. First, use of annotation data was limited to the Human lincRNA Catalog at Broad Institute \[[@B20]\], although other annotations of human lincRNA are also available \[[@B30]\]. More information about lincRNA will help to identify more NAGNAG alternative splicing. Second, biological significance and potential disease impact of NAGNAG alternative splicing was only projected computationally, and awaits confirmation through further proteomic studies. For example, results of gene ontology analysis by application for genes targeted by NAGNAG acceptors in lincRNA indicated that these genes were all functionally engaged in transcription regulation (ANP32A, CHD9, NR1D1, POLR3G, VEZF1, ZNF227) and signalling (CRP, CTBS, FAM174B, FAM20C, GDF10, ITGA4, NETO1, RGMA, TMEM132C, OSMR). Further, analysis for potential disease association of the neighbouring genes revealed that these genes represented candidate genes associated with risk for many important diseases, including hypertension, obesity, and cancer, among others (see Supplementary Table S2 for a complete list).

Importantly, bioinformatics analysis has proved to be an invaluable tool in the investigation of the role of alternative splicing from numerous perspectives including microarray analysis, alternative splicing prediction utilizing comparative genomic approaches, identification and depiction of isoform and splicing patterns, definition of regulation of alternative splicing, delineation of functional impact, and its role in defining evolutionary and adaptive processes, among other investigations \[[@B19]\]. To delineate alternative splicing in lincRNA, further investigations are essential in unraveling their functional and regulatory roles through application of bioinformatic, genetic, and proteomic approaches. The evolutionary aspect of lincRNA NAGNAG alternative splicing across different species can also be studied in the future.
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![NAGNAG alternative splicing can result in two isoforms. The NAGNAG acceptors at the 3′-end can be either at site 1 or site 2, are three nucleotides apart, and exhibit the "NAGNAG" motif signature.](BMRI2014-736798.001){#fig1}

![Sequence logos for 30 bp flanking sequences for 3′ splice sites. The logos are divided into four groups based on the chromosome strand and ratio of read counts of site 1 to site 2.](BMRI2014-736798.002){#fig2}

![Heat map for the ratio of the NAGNAG isoforms at the two alternative splice sites (site 1 and site 2). Row represents 31 NAGNAG acceptors while column represents various tissues. Ratio \> 0: site 2 is preferred. Ratio \< 0: site 1 is preferred.](BMRI2014-736798.003){#fig3}

###### 

NAGNAG acceptors in lincRNA confirmed by RNA-seq.

  Transcript ID    linc name          chr     Site 1      Site 1 existence   Site 2      Site 2 existence   Strand   Neighbouring gene
  ---------------- ------------------ ------- ----------- ------------------ ----------- ------------------ -------- -------------------
  TCONS_00000929   linc-CMPK1-3       chr1    47645537    Data 1, 2          47645540    Data 1, 2          \+       CMPK1
  TCONS_00001552   linc-CTBS-1        chr1    85084564    Data 1             85084567    Data 1             −        CTBS
  TCONS_00002502   linc-CRP-1         chr1    159746542   Data 1             159746545   Data 1             −        CRP
  TCONS_00002232   linc-IARS2-3       chr1    219414541   Data 1, 2          219414544   Data 1             \+       IARS2
  TCONS_00018502   linc-GDF10-1       chr10   48515547    Data 1             48515550    Data 1             −        GDF10
  TCONS_00021357   linc-BEST3-1       chr12   70124473    Data 1             70124476    Data 2             −        BEST3
  TCONS_00020623   linc-TMEM132C-14   chr12   126580786   Data 1, 2          126580789   Data 1             \+       TMEM132C
  TCONS_00023051   linc-DIO3-8        chr14   101363930   Data 2             101363933   Data 2             \+       DIO3
  TCONS_00023721   linc-ANP32A-1      chr15   69753046    Data 2             69753049    Data 1, 2          −        ANP32A
  TCONS_00023791   linc-FAM174B-1     chr15   93325371    Data 1, 2          93325374    Data 1             −        FAM174B
  TCONS_00023799   linc-RGMA-7        chr15   95753867    Data 1             95753870    Data 1             −        RGMA
  TCONS_00024399   linc-CHD9-6        chr16   51806287    Data 1             51806290    Data 1             \+       CHD9
  TCONS_00025631   linc-NR1D1-1       chr17   38277663    Data 1             38277666    Data 1, 2          −        NR1D1
  TCONS_00025146   linc-VEZF1-1       chr17   56066627    Data 1, 2          56066630    Data 1, 2          −        VEZF1
  TCONS_00026560   linc-NETO1-1       chr18   71351479    Data 1, 2          71351482    Data 1, 2          −        NETO1
  TCONS_00027051   linc-ZNF227-1      chr19   44700207    Data 1             44700210    Data 1             \+       ZNF227
  TCONS_00004960   linc-ITGA4-2       chr2    181940923   Data 1             181940926   Data 1             \+       ITGA4
  TCONS_00003507   linc-GPR55-1       chr2    231856751   Data 1, 2          231856754   Data 2             −        GPR55
  TCONS_00029585   linc-RASD2-1       chr22   35850418    Data 1             35850421    Data 1             \+       RASD2
  TCONS_00005471   linc-TMEM14E-2     chr3    153103176   Data 1             153103179   Data 1             −        TMEM14E
  TCONS_00007527   linc-SPATA18-1     chr4    52912845    Data 1, 2          52912848    Data 1, 2          \+       SPATA18
  TCONS_00009387   linc-OSMR-1        chr5    38792356    Data 1             38792359    Data 1             \+       OSMR
  TCONS_00010010   linc-POLR3G-10     chr5    87581558    Data 1, 2          87581561    Data 1, 2          \+       POLR3G
  TCONS_00010012   linc-POLR3G-10     chr5    87583253    Data 1, 2          87583256    Data 1             \+       POLR3G
  TCONS_00009724   linc-LYSMD3-2      chr5    90610061    Data 1, 2          90610064    Data 1, 2          −        LYSMD3
  TCONS_00010581   linc-MGAT1-2       chr5    180257403   Data 1             180257406   Data 1             −        MGAT1
  TCONS_00012396   linc-PSMG4-1       chr6    3257557     Data 1             3257560     Data 1             \+       PSMG4
  TCONS_00011322   linc-FAM135A-1     chr6    71104930    Data 1             71104933    Data 1             \+       FAM135A
  TCONS_00012862   linc-FAM20C-2      chr7    153409      Data 1             153412      Data 1             \+       FAM20C
  TCONS_00014103   linc-SEPT7-1       chr7    35756638    Data 1             35756641    Data 1, 2          \+       SEPT7
  TCONS_00014833   linc-UTP23-3       chr8    112757671   Data 1, 2          112757674   Data 2             \+       UTP23
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